You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Active specific immunotherapy is a promising but investigational modality in the management of cancer patients. Currently, several different cancer vaccine formulations such as peptides, proteins, antigen-pulsed dendritic cells, whole tumor cells, etc. in combination with various adjuvants and carriers are being evaluated in clinical trials (1-3). To determine the optimal cancer vaccine strategy, a surrogate immunological end-point that correlates with clinical outcome needs to be defined, since it would facilitate the rapid comparison of these various formulations. Traditional immunological assays such as ELISA, proliferation and cytotoxicity assays can detect immune responses in vaccinated...
None
The closing years of the 19th century and the start of the 20th century witnessed the emergence of microbiology and immunology as discrete sci- tific disciplines, and in the work of Roux and Yersin, perhaps the first benefits of their synergy—immunotherapy against bacterial infection. As we advance into the new millennium, microbiology and immunology again offer a c- ceptual leap forward as antibody phage display gains increasing acceptance as the definitive technology for monoclonal production and unleashes new - portunities in immunotherapy, drug discovery, and functional genomics. In assembling Antibody Phage Display: Methods and Protocols, we have aimed to produce a resource of real va...
Five startling discoveries about how bacteria grow were recently made -- about 100 yr after they should have been made. Scientists back then misled themselves by not vetting out a new method for growing bacteria developed by a New Jersey woman while working in the Berlin lab of a soon-to-be Nobel Laureate. Oddly, he never used it. But everyone else did, and a faulty paradigm emerged from its use and is still in vogue today. The missed discoveries and faulty paradigm had little impact on the achievements of Science during the 20th Century but not so regarding those required in the 21st. The imbedded paradigm must be corrected if we are to effectively combat epidemics and bioterrorism. This is a true story told first hand of the discoveries and frustrations to correct this faulty paradigm.
Traditionally, the interplay between cancer cells and host immunity has been studied systemically. Recent studies, however, indicate that the tumor microenvironment is unique in providing both supportive and inhibitory factors that determine the fate of the tumor and its host. This volume compiles reviews on innate and adaptive immune responses at the tumor microenvironment with emphasis on positive and negative outcomes that affect the progression of the disease.
First multi-year cumulation covers six years: 1965-70.
First multi-year cumulation covers six years: 1965-70.
Offering an overview of radioimmunotherapy, this book represents a comprehensive amalgamation of the radiation physics, chemistry, radiobiology, tumor models, and clinical data for targeted radionuclide therapy.